Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Histologically-confirmed Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01892137
What this trial is testing

Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05%

Who this might be right for
Actinic Keratosis
LEO Pharma 137
Large-scale testing (Phase 3)Study completedNCT00473343
What this trial is testing

Metvix PDT in Participant With "High Risk" Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Galderma R&D 102
Early research (Phase 1)Ended earlyNCT00124917
What this trial is testing

Phase I Study of Intensity Modulated Radiation Therapy for Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 6
Testing effectiveness (Phase 2)Study completedNCT01362127
What this trial is testing

Neoadjuvant Chemotherapy Versus Radiochemotherapy for Cancer of the Esophagus or Cardia

Who this might be right for
Carcinoma, Squamous CellAdenocarcinoma of the Esophagus and Gastric Cardia
Karolinska University Hospital 181
Testing effectiveness (Phase 2)Study completedNCT00409214
What this trial is testing

Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma

Who this might be right for
GliomaGlioblastoma MultiformeAnaplastic Astrocytoma
Light Sciences Oncology 18
Early research (Phase 1)Study completedNCT01294358
What this trial is testing

Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial

Who this might be right for
Histologically or Cytologically Confirmed Pancreatic CaUnresectable or Borderline Resectable Pancreatic Ca
National Cancer Institute (NCI) 7
Not applicableStudy completedNCT01465854
What this trial is testing

French Biological Observatory on Lung Cancer in Never Smokers

Who this might be right for
Lung Cancer
Intergroupe Francophone de Cancerologie Thoracique 422
Not applicableStudy completedNCT01226589
What this trial is testing

Pharmacist Discharge Medication Reconciliation Study

Who this might be right for
Medication Reconciliation
Alberta Health services 50
Not applicableNo Longer AvailableNCT03311542
What this trial is testing

Expanded Access for Pembrolizumab (MK-3475)

Who this might be right for
Melanoma (Skin)Melanoma RecurrentGlioblastoma Multiforme+2 more
Center Trials & Treatment
Testing effectiveness (Phase 2)Ended earlyNCT04327986
What this trial is testing

Immune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Advanced Pancreas Cancer

Who this might be right for
Histologically or Cytologically Confirmed Pancreatic CancerUnresectable or Borderline Resectable Pancreatic CancerPancreatic Neoplasms+2 more
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Study completedNCT01698905
What this trial is testing

Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 163
Testing effectiveness (Phase 2)Ended earlyNCT02811159
What this trial is testing

An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids

Who this might be right for
Uterine Fibroids
Repros Therapeutics Inc. 20
Early research (Phase 1)Study completedNCT01202032
What this trial is testing

Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid Tumors

Who this might be right for
Metastatic Renal Cell CarcinomaAdvanced Refractory Solid Tumors Histologically or Cytologically Confirmed
Centre Leon Berard 36
Large-scale testing (Phase 3)Ended earlyNCT06470451
What this trial is testing

Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL

Who this might be right for
CTCL/ Mycosis FungoidesCTCLMycosis Fungoides+1 more
Soligenix 70
Testing effectiveness (Phase 2)Study completedNCT02287129
What this trial is testing

Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal Junction

Who this might be right for
Adenocarcinoma of the Esophagogastric Junction
Technical University of Munich 75
Large-scale testing (Phase 3)Study completedNCT02599402
What this trial is testing

Nivolumab Combined With Ipilimumab Followed by Nivolumab Monotherapy as First-Line Treatment for Patients With Advanced Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 533
Early research (Phase 1)Ended earlyNCT04990479
What this trial is testing

Nous-PEV: a Novel Immunotherapy for Lung Cancer and Melanoma

Who this might be right for
Melanoma (Skin)Non-Small-Cell Lung Carcinoma
Nouscom SRL 7
Early research (Phase 1)Study completedNCT01189942
What this trial is testing

FOLFIRI Plus OMP-21M18 as 1st or 2nd-line Treatment in Subjects With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
OncoMed Pharmaceuticals, Inc. 18
Early research (Phase 1)Ended earlyNCT01278849
What this trial is testing

An Open-label, Dose Escalation Study to Assess the Pharmacokinetics of of ASA404 in Adult Cancer Patients With Impaired Hepatic Function

Who this might be right for
Histologically-proven and Radiologically-confirmed Solid Tumors
Novartis Pharmaceuticals 5
Not applicableStudy completedNCT00198406
What this trial is testing

A FRENCH SURVEY OF THE DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF ELDERLY PEOPLE WITH HISTOLOGICALLY/CYTOLOGICALLY CONFIRMED LUNG CANCER.

Who this might be right for
ELDERLY PEOPLENon-small Cell Lung Cancer
Intergroupe Francophone de Cancerologie Thoracique 1,653
Next Page